Man Group
ENTA icon

Man Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Man Group’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,234
Closed -$496K – 2419
2026
Q1 		$496K Sell
39,234
-4,613
-11% -$61.8K ﹤0.01% 2084
2025
Q4 		$691K Buy
43,847
+3,691
+9% +$46.9K ﹤0.01% 1792
2025
Q3 		$481K Buy
+40,156
New +$321K ﹤0.01% 1862
2024
Q1 		– Sell
-42,415
Closed -$399K – 2155
2023
Q4 		$399K Buy
+42,415
New +$395K ﹤0.01% 1744
2023
Q1 		– Sell
-13,698
Closed -$637K – 2118
2022
Q4 		$637K Buy
+13,698
New +$624K ﹤0.01% 1445
2021
Q1 		– Sell
-177,288
Closed -$7.46M – 1890
2020
Q4 		$7.46M Sell
177,288
-56,532
-24% -$2.49M 0.03% 577
2020
Q3 		$10.7M Buy
233,820
+63,496
+37% +$3.08M 0.04% 447
2020
Q2 		$8.55M Sell
170,324
-26,281
-13% -$1.36M 0.04% 418
2020
Q1 		$10.1M Sell
196,605
-103,480
-34% -$5.52M 0.07% 290
2019
Q4 		$18.5M Buy
300,085
+4,131
+1% +$256K 0.06% 381
2019
Q3 		$17.8M Buy
295,954
+190,743
+181% +$14.2M 0.07% 348
2019
Q2 		$8.88M Buy
105,211
+34,100
+48% +$3.07M 0.03% 680
2019
Q1 		$6.79M Buy
71,111
+39,023
+122% +$3.5M 0.03% 754
2018
Q4 		$2.27M Sell
32,088
-36,329
-53% -$2.79M 0.01% 1159
2018
Q3 		$5.85M Sell
68,417
-59,900
-47% -$6M 0.02% 901
2018
Q2 		$14.9M Sell
128,317
-147,425
-53% -$14.7M 0.06% 388
2018
Q1 		$22.3M Buy
+275,742
New +$21.2M 0.1% 203

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Man Group's ENTA Position: Q2 2026 in Review

Man Group sold out of Enanta Pharmaceuticals (ENTA) in Q2 2026, closing a stake of 39,234 shares — an estimated $496K sold.

Man Group first reported a position in ENTA in Q1 2018 and held it in 17 quarters. The position peaked at $22.3M in Q1 2018. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Man Group reported no remaining Enanta Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 39,234 Enanta Pharmaceuticals shares in Q2 2026, an estimated $496K.
  • Man Group first reported a position in Enanta Pharmaceuticals in Q1 2018 and held it in 17 quarters.
  • Man Group's Enanta Pharmaceuticals position peaked at $22.3M in Q1 2018.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.